The clinical sensitivity (detection of cancer by urine test of these three genes) of CD24, CD49f, and NANOG were 47.1% (8/17), 52.93% (9/17), and 52.93% (9/17), respectively (Fig. 4e). The gene discussed is CD24; the disease is cancer.